ALKS - Alkermes Non-GAAP EPS of $0.43 misses by $0.15 revenue of $350.4M misses by $9.87M
2024-05-01 07:07:03 ET
More on Alkermes
- Alkermes: Waking Up Narcolepsy Treatment With Promising Trial Data
- Alkermes plc: Collecting The Fruits Of The 2023 Spinoff
- Alkermes plc 2023 Q4 - Results - Earnings Call Presentation
- Alkermes Q1 2024 Earnings Preview
- Alkermes posts early-stage win for sleeping disorder therapy (update)